TOP 10 COMPANIES IN DIAGNOSTIC SPECIALTY ANTIBODIES MARKET

Diagnostic Specialty Antibodies Market Will Grow at A CAGR of 4.6% during the Forecast Period to Reach $39.99 Billion by 2029, Says “Meticulous Research^®. Antibodies play a vital role in the detection of foreign molecules (antigens). Antibodies are rapidly generated as a response to infections and have a diagnostic value. In terms of diagnostics, antibodies are used for the detection of infections, recognition of allergies, and measurement of hormones and other biological markers in the body fluids. Antibody-based immunoassays are the commonly preferred confirmatory diagnostic assays.

The diagnostic specialty antibody market is growing on account of the high burden of infectious and chronic diseases globally, increasing funding for clinical trials and research, increasing use of immunoassays in oncology, technological advancements in immunology, and high adoption of self-testing pregnancy detection kits. Further, initiatives by public and private organizations to increase COVID-19 testing offered many opportunities for market growth. In addition, untapped opportunities in emerging economies also offer favorable opportunities for market growth.

Here are the top 10 companies operating in the Diagnostic Specialty Antibodies Market 

Thermo Fisher Scientific Inc. (U.S.)

Founded in 1956 and is headquartered in Massachusetts, U.S., Thermo Fisher Scientific, Inc. is a healthcare company that operates its business in four major segments: Analytical Instruments, Life Sciences Solutions, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment offers products like reagents, consumables, and instruments used in biological and medical research, discovery, and production of vaccines and drugs. The Life Sciences Solutions segment comprises four businesses: Clinical Next Generation Sequencing, Biosciences, Genetic Sciences, and BioProduction. The Biosciences business offers diagnostic antibodies in addition to instruments, reagents, and consumables used in biological and medical research to discover new vaccines and drugs and to diagnose infections and diseases.

The company has a geographic presence in regions like North America, Europe, Asia-Pacific, and Others. The sales and marketing of the company is done through a direct sales force, third-party distributors, customer-service professionals, electronic commerce, and various catalogs. The company has a direct presence through its regional offices and production sites in various countries, including the U.S., Mexico, Brazil, Germany, Belgium, Austria, the U.K., Italy, the Netherlands, South Africa, the UAE, India, China, Japan, Australia, and South Korea. Fisher Scientific GmbH (Germany), Fisher Scientific (Austria) GmbH, and Fisher Scientific AG – Neuhofstrasse 11 (Switzerland) are some subsidiaries of the company offering diagnostic antibodies.

F. Hoffman-La Roche Ltd (Switzerland)

Founded in 1896 and headquartered in Basel, Switzerland, F. Hoffman-La Roche Ltd is a multinational healthcare company. The company offers its products in two business segments: Pharmaceuticals and Diagnostics. The company’s Diagnostics business is further categorized into four segments: Centralized and Point of Care Solutions, Molecular Diagnostics, Tissue Diagnostics, and Diabetes Care. The Tissue Diagnostics segment provides a range of IVD antibodies for the diagnosis of breast cancer, cervical cancer, gastrointestinal or colorectal cancer, lung cancer, dermatopathology, and hematopathology.

The company serves clients across different geographies, namely in the Americas, Europe, Africa (EMEA), Asia Pacific, and Oceania. The company has a presence in over 100 countries globally through its affiliates and owns R&D sites in 17 locations worldwide. The company employs 60,000 suppliers for providing raw materials, logistics services, research services, marketing, packaging, and other services globally. The company owns more than 140 diagnostic tools and over 850 diagnostic tests. Roche Diagnostics India Pvt. Ltd. (India), Roche Diagnostics Japan KK (Japan), and Roche Germany Holding GmbH (Germany) are some subsidiaries of the company offering diagnostic antibodies products.

Merck KGaA (Germany)

Founded in 1668 and headquartered at Hesse, GermanyMerck KGaA is a multinational company that operates its business in segments: Healthcare, Life sciences, and Performance Materials. The Life Science segment consists of three business units: Research Solutions, Process Solutions, and Applied Solutions business units. The Research Solutions business units offer products and services for the biotechnology, pharmaceutical, and academic research laboratories. The business unit includes the biological and chemical tools for scientific discoveries. The Research Solutions business unit of the segment offers diagnostic antibodies.

The company has a geographic presence in Europe, North America, Asia-Pacific, Latin America, and the Middle East & Africa. In terms of distribution channel, the ecommerce activities of the Life Science segment of the company generally function through the Sigma-Aldrich platform. Merck Pty. Ltd (Australia), Sigma-Aldrich Brasil Ltda. (Brazil), Merck Ltd (China) and Sigma-Aldrich Israel Ltd. (Israel) are some subsidiaries of the company offering diagnostic antibodies.

Abcam plc (U.K.)

Founded in 1998 and is headquartered in Cambridge, U.K., Abcam plc is a life science company that recognizes, develops, and distributes high-quality reagents and tools for life science research. The company has only one reportable segment-sales of antibodies and related products through which the company primarily offers antibodies and related products for diagnostics, scientific research, and drug discovery. The company offers over 450 antibodies validated for use on third-party platforms and diagnostic uses. The company’s products are used in research institutes, pharmaceuticals, biotechnology, diagnostics companies, and academic institutions.

The company has seven manufacturing facilities and seven distribution centers globally. Through the network of distributors, the company serves customers across 130 countries. Expedeon Limited (U.K), Abcam (U.S.) Limited (U.S.) and Innova BioSciences Limited (U.K.) are some of the company’s subsidiaries offering diagnostic antibodies products.

Bio-Rad Laboratories, Inc. (U.S.)

Founded in 1952 and headquartered in California, U.S., Bio-Rad Laboratories, Inc. manufactures and distributes clinical diagnostics and life science research products. The company operates its business in two segments: Life Science and Clinical Diagnostics. The Clinical Diagnostics segment provides test systems, informatics systems, test systems, and specialized quality controls to serve clinical laboratories globally. The company provides diagnostic antibodies through the Clinical Diagnostics segment.

The company’s sales occur through direct sales force and sales management personnel. The company has direct distribution channels in 36 countries outside the U.S. and the distribution of products functions through subsidiaries. However, sales are done through distributors and agents in some locations, including 36 countries. The company has its geographic presence in Europe, Asia, the U.S., Canada, and Latin America. The company has manufacturing and distribution facilities in regions like the western U.S., Switzerland, France, Germany, and Singapore. Bio-Rad Laboratories India Pvt. Ltd (India), Bio-Rad Laboratories Pty., Ltd. (Australia), Bio-Rad Laboratories GmbH (Germany), and Bio-Rad Laboratories (New Zealand) Pty Ltd (New Zealand) are some subsidiaries of the company offering diagnostic antibodies.

Meticulous Research in its latest publication on Diagnostic Specialty Antibodies Market has predicted the growth of 4.6% during the forecast year 2022-2029.

Agilent Technologies, Inc. (U.S.)

Founded in 1999 and headquartered in California, U.S., Agilent Technologies, Inc. provides consumables, instruments, software, and services for laboratory workflow. The company operates its business in three segments: Life Sciences and Applied Markets Business, the Agilent CrossLab business, and the Diagnostics and Genomics business. The Diagnostic and Genomic business is further categorized based on the workflows into Pathology, Specific Proteins and Flow Reagents, Companion Diagnostics, Target Enrichment, Cytogenetic Research Solutions and Microarrays, PCR and qPCR Instrumentation and Molecular Biology Reagents, Nucleic Acid Solutions and Automated Electrophoresis and Microfluidics. The pathology products consist of clinical solutions for tissue-based cancer diagnostics and include reagents, antibodies, instruments, and software used in primary and advanced cancer diagnostics.

The company sells its products through direct sales, distributors, manufacturer’s representatives, resellers, and electronic commerce. The company’s primary R&D and manufacturing sites are located in the U.S., Germany, Malaysia, Australia, China, Denmark, Italy, Japan, Singapore, and the U.K. The company has its geographic presence in the Americas, Europe, and the Asia-Pacific. ELITechGroup Australia Pty Ltd (Australia), Agilent Technologies India Pvt. Ltd. (India.), and Agilent Technologies Co. Ltd (China) are some subsidiaries of the company offering diagnostic antibodies. In February 2021, Agilent Technologies, Inc. was ranked second in Barron’s annual list of America’s Most Sustainable Companies.

Becton, Dickinson and Company (U.S.)

Founded in 1897 and headquartered in New Jersey, U.S., Becton, Dickinson and Company is a medical technology company involved in the manufacturing, developing, and selling of a range of laboratory equipment, medical supplies, devices, and diagnostic products. The company offers its products to life science researchers, physicians, healthcare institutions, the pharmaceutical industry, clinical laboratories, and others. The company operates its business majorly in three segments: BD Life Sciences, BD Medical, and BD Interventional. The BD Life Sciences segment comprises products for safe collection and transportation of diagnostics specimens and instruments and reagent systems to diagnose diseases like healthcare-associated infections, infectious diseases, and cancers. The BD Life Sciences segment is further categorized into Integrated Diagnostic Solutions and Biosciences. The Biosciences unit comprises of products like reagent systems for life science research, antibodies and kits for performing cell analysis, fluorescence-activated cell sorters and analyzers; solutions for high-throughput single-cell gene expression analysis, and clinical oncology, transplantation diagnostic/monitoring, and immunological human immunodeficiency virus (HIV) reagents and analyzers.

The company has manufacturing facilities in North America, Europe, the Middle East, Africa, Latin America, Greater Asia, and Canada. The company’s distribution operations generally occur through independent distribution channels and sales representatives. The R&D activities of the company take place in the operating units and the Research triangle park of North Carolina (U.S.). The key R&D practices occur in North America; however, outside North America, the R&D activities occur in countries like China, India, France, Ireland, and Singapore. BD Australia Pty Ltd (Australia), BD India Pvt. Ltd. (India), Becton, Dickinson U.K. Limited (U.K.), Becton Dickinson S.A. (Spain), and Becton Dickinson Korea Ltd. (Korea) are some subsidiaries of the company offering diagnostic antibodies.

Creative Diagnostics (U.S.)

Founded in 2005 and headquartered in New York, U.S., Creative Diagnostics is a biotechnology manufacturing company engaged in manufacturing and supplying viral antigens, antibodies, critical assay reagents, and innovative diagnostic components. The company provides manufacturing services and contract biologic R&D to the diagnostic manufacturers in the biopharmaceutical market. The company assists its clients by rapidly developing, manufacturing, and commercializing point of care lateral flow, flow through, and ELISA assays. The company’s specialties produce visual colloidal gold, fluorescent, and paramagnetic labels and sensitive, quantitative, and reader-based tests.

The company has its global presence in North America, Europe, Asia Pacific, and Latin America. The company also offers its products globally with the help of distributors. Genxbio Health Sciences Pvt. Ltd. (India), Huntingtree Associates Ltd (New Zealand), and 2BScientific Ltd (U.K.) are some subsidiaries of the company offering diagnostic antibodies.

Rockland Immunochemicals, Inc. (U.S.)

Founded in 1962 and headquartered in Pennsylvania, U.S; Rockland Immunochemicals, Inc. is a biotechnology company involved in manufacturing tools for applied, basic, and clinical research in gene therapy, functional genomics, and drug discovery markets. The company offers antibodies, proteins, peptides, kits, epitome tags, controls, blood products, cell lysates, and supporting reagents. The company’s antibody products are used for high throughput screening (HTS), diagnostic kit production, drug discovery, and life science research. The company has a manufacturing facility for antibody and protein production in the U.S.

The company has its geographic presence globally, owing to its strong distribution network. The company has its global presence in North America, Europe, Asia Pacific, Latin America, and Africa. VWR International (U.S.), Thomas Scientific (U.S.), Jomar Life Research (Australia), Sellex, Inc. (Brazil), and BioNordika Denmark A/S (Denmark) are some distributors of the company offering diagnostic antibodies.

Santa Cruz Biotechnology, Inc. (U.S.)

Founded in 1991 and is headquartered in Texas, U.S, Santa Cruz Biotechnology is a biotechnology company that develops products for the biomedical research market. The company is focused on developing research monoclonal antibodies, labware, biochemical, and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) products. The company’s antibodies are used to identify and treat diseases. The company offers primary and secondary antibodies for use in applications like western blot, immunohistochemistry, immunofluorescence, immunoprecipitation, and flow cytometry.

The company has its geographic presence in regions like North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The company has an indirect presence globally owing to its strong distribution network. Bio-Strategy PTY Limited (Australia), Interprise Brazil (Brazil), EXBIO Praha, a.s. (Czech Republic), CliniSciences (France), Insight Biotechnology Ltd (U.K.) are some distributors of the company offering diagnostic antibodies.

Authoritative Research on the Diagnostic Specialty Antibodies Market – Global Opportunity Analysis and Industry Forecast (2022-2029)

Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:

• Recent financial performance
• Key products
• Significant company strategies
• Partnerships and acquisitions

The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.